Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann E Wasmuth

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 30, 2005
Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liverAndreas Geier, Christoph G Dietrich, Sebastian Voigt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2004
Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis CAndreas Geier, Michael Reugels, Ralf Weiskirchen, et al.
Hepatology (Baltimore, Md.)|September 22, 2012
Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytesHacer Sahin, Erawan Borkham-Kamphorst, Nicole T do O, et al.
Nature Genetics|July 5, 2005
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humansSonja Hillebrandt, Hermann E Wasmuth, Ralf Weiskirchen, et al.
Hepatology (Baltimore, Md.)|February 18, 2010
CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosisMirko Moreno Zaldivar, Katrin Pauels, Philipp von Hundelshausen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 7, 2017
Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortalityJennifer M Lehmann, Karina Claus, Christian Jansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2015
Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shuntMarie-Luise Berres, Jennifer Lehmann, Christian Jansen, et al.
Journal of Hepatology|December 15, 2007
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infectionHermann E Wasmuth, Mirko Moreno Zaldivar, Marie-Luise Berres, et al.
The American Journal of Pathology|November 13, 2012
Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosisIna V Martin, Erawan Borkham-Kamphorst, Stephanie Zok, et al.
Frontiers in Physiology|April 12, 2019
Platelet Factor 4 Attenuates Experimental Acute Liver Injury in MiceHannah K Drescher, Elisa F Brandt, Petra Fischer, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 30, 2005
Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liverAndreas Geier, Christoph G Dietrich, Sebastian Voigt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2004
Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis CAndreas Geier, Michael Reugels, Ralf Weiskirchen, et al.
Hepatology (Baltimore, Md.)|September 22, 2012
Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytesHacer Sahin, Erawan Borkham-Kamphorst, Nicole T do O, et al.
Nature Genetics|July 5, 2005
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humansSonja Hillebrandt, Hermann E Wasmuth, Ralf Weiskirchen, et al.
Hepatology (Baltimore, Md.)|February 18, 2010
CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosisMirko Moreno Zaldivar, Katrin Pauels, Philipp von Hundelshausen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 7, 2017
Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortalityJennifer M Lehmann, Karina Claus, Christian Jansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2015
Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shuntMarie-Luise Berres, Jennifer Lehmann, Christian Jansen, et al.
Journal of Hepatology|December 15, 2007
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infectionHermann E Wasmuth, Mirko Moreno Zaldivar, Marie-Luise Berres, et al.
The American Journal of Pathology|November 13, 2012
Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosisIna V Martin, Erawan Borkham-Kamphorst, Stephanie Zok, et al.
Frontiers in Physiology|April 12, 2019
Platelet Factor 4 Attenuates Experimental Acute Liver Injury in MiceHannah K Drescher, Elisa F Brandt, Petra Fischer, et al.
Pageof 8